Carbapenem resistant Enterobacteriaceae - second update
Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Risk assessment: Update on autochthonous dengue cases in Madeira, Portugal
This is the first sustained transmission of dengue in the European Union since the 1920s. Autochthonous transmission is likely to continue until the end of the year when mosquito density will probably decrease.
Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2016
This report covers the events, threats and actions taken in 2016 related to the findings of routine activities carried out by the ECDC epidemic intelligence team.
Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2018
This report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2018 and the actions taken related to these findings.
Communicable disease threats to public health in the European Union - Annual Epidemiological Report for 2017
This report covers the events, threats and actions taken in 2017 related to the findings of routine activities carried out by the ECDC epidemic intelligence team. The objective of epidemic intelligence at ECDC is to rapidly detect and assess public health events of any origin to ensure EU health security as defined in ECDC’s mandate.
Risk assessment: Epidemiological situation of West Nile virus infection in the European Union - Update, 13 July 2012
On 7 and 10 July, the Hellenic Centre for Disease Control and Prevention (KEELPNO) reported the first two human cases of West Nile virus (WNV) infection in Greece this year. When looking at the epidemiology of WNV infection in Greece since 2010, one can observe a progressive geographical expansion of WNV transmission throughout the country. For this reason, these newly confirmed cases in Athens do not come unexpected.
Rapid risk assessment: Zika virus disease epidemic, eighth update
This eighth update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas. It provides updated information for those travelling to and returning from affected countries and for EU citizens residing in areas with active transmission. It reviews available information on the association between Zika virus infection and congenital central nervous system malformations, including microcephaly, as well as the association between Zika virus infection and Guillain–Barré syndrome. It also proposes a range of mitigation measures for EU/EEA Member States to consider.
Rapid risk assessment: Zika virus disease epidemic - 9th update, 28 October 2016
This update of ECDC’s rapid risk assessment on the Zika epidemic considers the recent epidemiological and scientific information in light of the risk to Europe and European citizens.
Rapid Outbreak Assessment: Update: Outbreak of hepatitis A virus infection in Italy and Ireland
Since publishing the ’Joint ECDC-EFSA rapid outbreak assessment: Outbreak of hepatitis A virus infection in residents and travellers to Italy’ in May, new information has emerged as a result of the epidemiological, microbiological and environmental investigations. Therefore, ECDC has updated its previous assessment.